Health care and life sciences enforcement is a top priority in 2026, and the playbook is becoming both broader and more coordinated. Federal prosecutors and state attorneys general are continuing to press traditional fraud and abuse theories, but they are doing so with more sophisticated data tools, more frequent multi-agency actions and a willingness to package payment integrity issues with related theories involving controlled substances, consumer protection and privacy. In practical terms, issues that once might have been managed as a single compliance matter can now escalate quickly into parallel exposure across civil False Claims Act investigations, criminal inquiries, administrative action and state enforcement litigation.
Read the full article: 2026 DOJ and State AG Enforcement Trends for Health Care and Life Sciences //
Source: https://www.medicaleconomics.com/view/2026-doj-and-state-ag-enforcement-trends-for-health-care-and-life-sciences